Compare Enzyme (MLN) vs Sologenic (SOLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Sologenic — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Sologenic trades at Rp751.86 (market cap Rp312,64M, Rp1,6M 24h volume). The key difference: Sologenic is far larger — about 2.3× Enzyme's market cap, and Sologenic's supply is capped (398,8M / 400M SOLO (100%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Sologenic for 24 Days on average.
| MLN | SOLO | |
|---|---|---|
Market Cap | Rp134,13M | Rp312,64M |
Volume (24h) | Rp104,56M | Rp1,6M |
Circulating Supply | 3,3M MLN | 398,8M / 400M SOLO (100%) |
Typical Hold Time | 29 Days | 24 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Sologenic (SOLO) maintains a market cap of Rp312.64 million with near-full circulating supply of 398.8 million tokens out of 400 million max. The asset shows moderate network activity with 24-day average hold time indicating stable holder behavior. Recent trading patterns suggest consolidation within a narrow range as the token approaches full distribution.
Outlook remains neutral with limited price discovery due to low trading volumes. Key opportunity lies in potential ecosystem expansion, while major risks include liquidity constraints and regulatory uncertainty common to emerging crypto assets. Investors should monitor on-chain activity for signs of renewed interest.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Sologenic
Sologenic is reshaping the asset trading landscape by integrating tokenized securities, crypto assets, and NFTs. The ecosystem is supported by two distinct teams: Sologenic.org (the SOLO Core Team), which focuses on expanding Sologenic as a decentralized ecosystem, and Sologenic.com, which is dedicated to launching key use cases such as securities tokenization. This dual approach ensures both the growth of the ecosystem and practical utility for users.
Read more on SOLO →
